These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29413372)

  • 1. Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study.
    Madelaire C; Gislason G; Kristensen SL; Fosbøl EL; Bjerre J; D'Souza M; Gustafsson F; Kober L; Torp-Pedersen C; Schou M
    JACC Heart Fail; 2018 Feb; 6(2):156-167. PubMed ID: 29413372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
    Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.
    Madelaire C; Schou M; Nelveg-Kristensen KE; Schmiegelow M; Torp-Pedersen C; Gustafsson F; Køber L; Gislason G
    Int J Cardiol; 2016 Oct; 221():944-50. PubMed ID: 27441473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
    Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
    Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population?
    Bermingham M; Shanahan MK; O'Connell E; Dawkins I; Miwa S; O'Hanlon R; Gilmer J; McDonald K; Ledwidge M
    Circ Heart Fail; 2014 Mar; 7(2):243-50. PubMed ID: 24493706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
    Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
    J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of new-onset atrial fibrillation complicating acute myocardial infarction on heart failure.
    Luo J; Xu S; Li H; Li Z; Liu B; Qin X; Gong M; Shi B; Wei Y
    ESC Heart Fail; 2020 Oct; 7(5):2762-2772. PubMed ID: 32578394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.
    Fudim M; Liu PR; Shrader P; Blanco RG; Allen LA; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Hylek E; Go AS; Thomas L; Peterson ED; Piccini JP
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Bennaghmouch N; de Veer AJWM; Bode K; Mahmoodi BK; Dewilde WJM; Lip GYH; Brueckmann M; Kleine E; Ten Berg JM
    Circulation; 2018 Mar; 137(11):1117-1129. PubMed ID: 29101289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study.
    Melgaard L; Gorst-Rasmussen A; Rasmussen LH; Lip GY; Larsen TB
    PLoS One; 2016; 11(3):e0152269. PubMed ID: 27015524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment.
    Di Tullio MR; Qian M; Thompson JLP; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GYH; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
    ESC Heart Fail; 2018 Oct; 5(5):800-808. PubMed ID: 30015405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study.
    Bang CN; Gislason GH; Greve AM; Bang CA; Lilja A; Torp-Pedersen C; Andersen PK; Køber L; Devereux RB; Wachtell K
    J Am Heart Assoc; 2014 Jan; 3(1):e000382. PubMed ID: 24449803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study.
    Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH
    J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
    J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
    Larsen TB; Rasmussen LH; Skjøth F; Due KM; Callréus T; Rosenzweig M; Lip GY
    J Am Coll Cardiol; 2013 Jun; 61(22):2264-73. PubMed ID: 23562920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.